MO: the balance sheet

MyFinsight

For the year ending 2025-12-31, MO has $35,017M in assets. $38,469M in debts. $4,474M in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
64.80%
Quick Ratio
53.11%
Cash Ratio
48.87%
Debt to Asset Ratio
109.86%
Unit: Million (M) dollars
Assets Breakdown
Other intangible assets, net
Investments in equity securities
Goodwill
Others
Liabilities Breakdown
Cost of repurchased stock (1,131...
Earnings reinvested in the busin...
Long-term debt
Others

Balance Sheets	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Cash and cash equivalents	4,474	3,127	3,686	4,030
Receivable from the sale of iqos system commercialization rights	-	-	0	1,721
Receivables	263	177	71	48
Leaf tobacco	531	591	649	704
Other raw materials	245	190	204	186
Work in process	13	21	22	24
Finished product	281	278	340	266
Inventory, net	1,070	1,080	1,215	1,180
Income taxes	-	93	496	-
Other current assets	125	36	117	241
Total current assets	5,932	4,513	5,585	7,220
Land and land improvements	125	124	123	123
Buildings and building equipment	1,574	1,552	1,535	1,478
Machinery and equipment	2,653	2,662	2,684	2,578
Construction in progress	320	199	240	248
Property, plant and equipment, at cost	4,672	4,537	4,582	4,427
Less accumulated depreciation	2,962	2,920	2,930	2,819
Property, plant and equipment, net	1,710	1,617	1,652	1,608
Goodwill	5,787	6,945	6,791	5,177
Other intangible assets, net	11,876	12,973	13,686	12,384
Investments in equity securities	8,617	8,195	10,011	9,600
Other assets	1,095	934	845	965
Total assets	35,017	35,177	38,570	36,954

Current portion of long-term debt	1,569	1,527	1,121	1,556
Accounts payable	750	700	582	552
Marketing	928	688	716	599
Settlement charges	2,178	2,354	2,563	2,925
Other	1,947	1,780	1,902	1,299
Deferred gain from the sale of iqos system commercialization rights	-	0	2,700	-
Dividends payable	1,782	1,732	1,735	1,685
Total current liabilities	9,154	8,781	11,319	8,616
Long-term debt	24,140	23,399	25,112	25,124
Deferred income taxes	3,370	3,749	2,799	2,897
Accrued pension costs	122	136	130	133
Accrued postretirement health care costs	939	935	1,079	1,083
Deferred gain from the sale of iqos system commercialization rights	-	-	0	2,700
Other liabilities	744	365	1,621	324
Total liabilities	38,469	37,365	42,060	40,877
Common stock, par value 0.33 1/3per share (2,805,961,317 shares issued)	935	935	935	935
Additional paid-in capital	5,921	5,905	5,906	5,887
Earnings reinvested in the business	35,452	35,516	31,094	29,792
Accumulated other comprehensive losses	-2,627	-2,400	-2,673	-2,771
Cost of repurchased stock (1,131,643,020 shares at december31, 2025 and 1,115,309,450 shares at december31, 2024)	43,183	42,194	38,802	37,816
Total stockholders equity (deficit) attributable to altria	-3,502	-2,238	-3,540	-3,973
Noncontrolling interest	50	50	50	50
Total stockholders equity (deficit)	-3,452	-2,188	-3,490	-3,923
Total liabilities and stockholders equity (deficit)	35,017	35,177	38,570	36,954

Unit: Million (M) dollars (except for numbers of shares and EPS).

MyFinsight

Balance Sheets Overview

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Balance Sheets Overview

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets